logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Michael Charlton

madrigal pharmaceuticals

92H指数
405论文数
4.2W被引数
收录论文 206
发表时间
logo
Response to “Aspirin for Primary Prevention in Metabolic Dysfunction-Associated Steatotic Liver Disease”对 “阿司匹林用于代谢功能障碍相关的脂肪性肝病的一级预防” 的反应
errHepatology Research
IF3.4
err2026-01-22
err0
PREAI
errTsubasa Tsutsumi; Michael R. Charlton; Takumi Kawaguchi; Mary E. Rinella
err分享
err收藏
Assessing predictive performance of FIB-4 in settings with lower prevalence of liver fibrosis评估FIB-4在肝纤维化患病率较低环境中的预测性能
errClinical Gastroenterology and Hepatology
IF12
err2025-12-23
err0
PREAI
errMary E. Rinella; Michael R. Charlton; Yestle Kim; Suneil Hosmane; Tom O’Connell
err分享
err收藏
Aspirin Use and Mediterranean Diet Adherence as Factors Associated With Overall Mortality in Patients With MASLD in NHANES阿司匹林使用和地中海饮食依从性作为与MASLD患者全因死亡率相关的因素在NHANES中
errHEPATOLOGY RESEARCH
IF3.4
err2025-11-01
err0
PREAI
errTsutsumi, Tsubasa; Charlton, Michael R.; Oddo, Vanessa M.; Vilt, Sarah; Kim, Hee Yeon; Micic, Dejan; Odenwald, Matthew A.; Kawaguchi, Takumi; Mcdonald, Edwin K.; Rinella, Mary E.
err分享
err收藏
Efficacy and safety of ervogastat alone and in combination with clesacostat in patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (MIRNA): results from a phase 2, randomised, double-blind, double-dummy study厄沃格斯特单药及联合克莱萨科斯特治疗活检确诊的代谢功能障碍相关脂肪性肝炎伴F2-F3期肝纤维化患者的疗效与安全性（MIRNA研究）：一项2期、随机、双盲、双模拟试验的结果
errThe Lancet Gastroenterology & Hepatology
IF0
err2025-07-31
err0
PREAI
errVincent Wai-Sun Wong; Neeta B Amin; Hirokazu Takahashi; Amanda Darekar; Frank Tacke; Jan Kiszko; Hector Rodriguez; Atsushi Nakajima; Naim Alkhouri; Michael Charlton; Quentin M Anstee
err分享
err收藏
Liver Transplantation Changing Indications and Changing Candidates肝移植：变化的适应证与变化的患者人群
errCLINICS IN LIVER DISEASE
IF4.1
err2025-05-01
err0
PREAI
errMichael Charlton; Mary E. Rinella
err分享
err收藏
The pleiotropic effects of glucagon-like peptide-1 receptor agonists in patients with metabolic dysfunction-associated steatohepatitis: a review for gastroenterologists胰高血糖素样肽-1受体激动剂对代谢功能障碍相关脂肪性肝炎患者的多效性作用: 胃肠病学家综述
errEXPERT OPINION ON INVESTIGATIONAL DRUGS
IF4.1
err2025-02-27
err0
PREAI
errAlkhouri, Naim; Charlton, Michael; Gray, Meagan; Noureddin, Mazen
err分享
err收藏
Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis专家小组建议: 启动和监测MASH/NASH和中度至非肝硬化晚期纤维化患者的Resmetirom的实际临床应用
errCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
IF12
err2024-12-01
err7
errOAAI
errNoureddin, Mazen; Charlton, Michael R.; Harrison, Stephen A.; Bansal, Meena B.; Alkhouri, Naim; Loomba, Rohit; Sanyal, Arun J.; Rinella, Mary E.
err分享
err收藏
Prevalence of Metabolic-Associated Steatohepatitis (MASH) and Advanced Fibrosis in At-Risk Pediatric Populations
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2024-10-01
err0
PREAI
errKim, Yestle; Charlton, Michael; Rezvani, Geoff; Saal, Gauri B.
err分享
err收藏
Estimation of the Eligible Population For Resmetirom Among Adults in the United States for Treatment of Non-Cirrhotic NASH with Moderate-to-Advanced Liver Fibrosis
errADVANCES IN THERAPY
IF4
err2024-09-18
err2
errOAAI
errFishman, Jesse; Kim, Yestle; Charlton, Michael R.; Smith, Zachary J.; O'Connell, Tom; Bercaw, Eric M.
err分享
err收藏
Colonel Stephen A. Harrison, MD - The passing of a Titan
errJOURNAL OF HEPATOLOGY
IF33
err2024-09-01
err0
errOAAI
errCharlton, Michael; Loomba, Rohit; Ratziu, Vlad; Rinella, Mary
err分享
err收藏
Characterizing Clinical and Economic Outcomes among Patients with MASH and Type 2 Diabetes Mellitus Treated with Glucagon-Like Peptide 1 (GLP1)-A Cohort Study
errDIABETES
IF7.5
err2024-06-14
err0
PREAI
errKim, Yestle; Qian, Christina; Fishman, Jesse; Szabo, Shelagh M.; Rochon, Hannah; Sun, Rosie; Medicis, Joe; Charlton, Michael
err分享
err收藏
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver FibrosisResmetirom治疗NASH肝纤维化的3期随机对照试验
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-02-08
err342
errOAAI
errHarrison, Stephen A.; Bedossa, Pierre; Guy, Cynthia D.; Schattenberg, Joern M.; Loomba, Rohit; Taub, Rebecca; Labriola, Dominic; Moussa, Sam E.; Neff, Guy W.; Rinella, Mary E.; Anstee, Quentin M.; Abdelmalek, Manal F.; Younossi, Zobair; Baum, Seth J.; Francque, Sven; Charlton, Michael R.; Newsome, Philip N.; Lanthier, Nicolas; Schiefke, Ingolf; Mangia, Alessandra; Pericas, Juan M.; Patil, Rashmee; Sanyal, Arun J.; Noureddin, Mazen; Bansal, Meena B.; Alkhouri, Naim; Castera, Laurent; Rudraraju, Madhavi; Ratziu, Vlad
err分享
err收藏
Macrophage RAGE activation is proinflammatory in NASH
errJCI INSIGHT
IF6.1
err2024-01-04
err5
errOAAI
errParthasarathy, Gopanandan; Mauer, Amy S.; Golla, Naresh; Daniel, P. Vineeth; Kim, Lily H.; Sidhu, Guneet S.; Marek III, George W.; Loeuillard, Emilien; Krishnan, Anuradha; Lee, Hyun Se Kim; Pavelko, Kevin D.; Charlton, Michael; Hirsova, Petra; Ilyas, Sumera I.; Malhi, Harmeet
err分享
err收藏
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance代谢功能障碍相关的脂肪变性肝病 (MASLD) 的内分泌方面: 超越胰岛素抵抗
errJOURNAL OF HEPATOLOGY
IF33
err2023-12-01
err41
errOAAI
errHutchison, Alan L.; Tavaglione, Federica; Romeo, Stefano; Charlton, Michael
err分享
err收藏
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis
errVIRUSES-BASEL
IF3.5
err2023-09-29
err7
errOAAI
errFlamm, Steven; Lawitz, Eric; Borg, Brian; Charlton, Michael; Landis, Charles; Reddy, K. Rajender; Shiffman, Mitchell; Alsina, Angel; Chang, Charissa; Ravendhran, Natarajan; Hernandez, Candido; Hezode, Christophe; Scherbakovsky, Stacey; Mercier, Renee-Claude; Samuel, Didier
err分享
err收藏
Liver Transplantation 2023: Status Report, Current and Future Challenges肝移植2023: 现状报告，当前和未来的挑战
errCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
IF12
err2023-07-01
err71
errOAAI
errTerrault, Norah A.; Francoz, Claire; Berenguer, Marina; Charlton, Michael; Heimbach, Julie
err分享
err收藏
The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection
errVIRUSES-BASEL
IF3.5
err2023-05-10
err2
errOAAI
errDavies, Elizabeth R.; Ryan, Kathryn A.; Bewley, Kevin R.; Coombes, Naomi S.; Salguero, Francisco J.; Carnell, Oliver T.; Biddlecombe, Sarah; Charlton, Michael; Challis, Amy; Cross, Eleanor S.; Handley, Alastair; Ngabo, Didier; Weldon, Thomas M.; Hall, Yper; Funnell, Simon G. P.
err分享
err收藏
Rational combination therapy for NASH: Insights from clinical trials and error
errJOURNAL OF HEPATOLOGY
IF33
err2023-05-01
err25
errOAAI
errRatziu, Vlad; Charlton, Michael
err分享
err收藏
SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum
errVIRUSES-BASEL
IF3.5
err2023-03-14
err8
errOAAI
errHandley, Alastair; Ryan, Kathryn A.; Davies, Elizabeth R.; Bewley, Kevin R.; Carnell, Oliver T.; Challis, Amy; Coombes, Naomi S.; Fotheringham, Susan A.; Gooch, Karen E.; Charlton, Michael; Harris, Debbie J.; Kennard, Chelsea; Ngabo, Didier; Weldon, Thomas M.; Salguero, Francisco J.; Funnell, Simon G. P.; Hall, Yper
err分享
err收藏
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States美国循环死亡后捐献和脑死亡后捐献的静态冷藏保存方案肝移植
errLIVER TRANSPLANTATION
IF3.9
err2022-09-01
err8
errOAAI
errCotter, Thomas G.; Odenwald, Matthew A.; Perez-Gutierrez, Angelica; Jayant, Kumar; DiSabato, Diego; Charlton, Michael; Fung, John
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
David Baltimore
H 指数: 209 · 论文数: 1.1K
D
Dennis R. Burton
H 指数: 172 · 论文数: 800
C
Charles M. Rice
H 指数: 166 · 论文数: 718
A
Arun J. Sanyal
H 指数: 166 · 论文数: 1.4K
M
Manel Esteller
H 指数: 165 · 论文数: 1.6K
查看更多